RSV Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Coronavirus NIH Launches Clinical Trials Network to Test COVID-19 Vaccines and Other Prevention Tools
Recent Comments